Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Haematologica|October 9, 2002
Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE)Fabrizio Fabris, Raffaella Scandellari, Maria Luigia Randi, et al.
Thrombosis and Haemostasis|February 13, 2004
Efficacy of AT in pre-eclampsia: a case-control prospective trialDelia M Paternoster, Sara Fantinato, Francesca Manganelli, et al.
European Journal of Haematology|April 29, 2016
Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years)Antonio Girolami, Elisabetta Cosi, Claudia Santarossa, et al.
Haematologica|November 5, 2002
Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemiaMaria Luigia Randi, Fabrizio Fabris, Elisabetta Ruzzon, et al.
Blood|May 16, 2002
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestationsMichael Kalafatis, Paolo Simioni, Daniela Tormene, et al.
Blood|February 21, 2004
Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpuraFabrizio Fabris, Raffaella Scandellari, Elisabetta Ruzzon, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Confirmation of the value of a modified long-distance polymerase chain reaction in the detection of inversion intron 22 in severe hemophilia a: a technical noteAnna Maria Lombardi, Laura Cabrio, Ezio Zanon, et al.
Cardiovascular & Hematological Disorders Drug Targets|September 12, 2017
Congenital FX Deficiency Rio Tercero: A New Heterozygous Missense Mutation (Cys241Gly) with a Potentiating Effect by a Polymorphism (c. 503-57C>T)Antonio Girolami, Salvador Minoldo, Silvia Ferrari, et al.
Haematologica|February 16, 2005
Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disordersMaria Luigia Randi, Elisabetta Ruzzon, Guido Luzzatto, et al.
Haematologica|June 13, 2003
Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factorAlessandra Casonato, Elena Pontara, Antonella Bertomoro, et al.
Pageof 16